OMX Stockholm 30
2.929,33
PKT
+39,04
PKT
+1,35
%
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.03.26 | AstraZeneca Overweight | Barclays Capital | |
| 31.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 31.03.26 | Volvo (B) Buy | UBS AG | |
| 31.03.26 | Volvo (B) Market-Perform | Bernstein Research | |
| 31.03.26 | AstraZeneca Overweight | Barclays Capital | |
| 31.03.26 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 30.03.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 30.03.26 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 30.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.03.26 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 27.03.26 | AstraZeneca Overweight | Barclays Capital | |
| 27.03.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 27.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.03.26 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 27.03.26 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 27.03.26 | Volvo (B) Market-Perform | Bernstein Research | |
| 27.03.26 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 26.03.26 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 26.03.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 26.03.26 | Hennes Mauritz (H M, H&M) Underweight | Barclays Capital | |
| 26.03.26 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 26.03.26 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 26.03.26 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 26.03.26 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 23.03.26 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 23.03.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 20.03.26 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 19.03.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 16.03.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.03.26 | Volvo (B) Market-Perform | Bernstein Research | |
| 10.03.26 | Nordea Bank Abp Registered Underweight | Barclays Capital | |
| 06.03.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 05.03.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 03.03.26 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 02.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.02.26 | AstraZeneca Buy | UBS AG | |
| 25.02.26 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 24.02.26 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 24.02.26 | Volvo (B) Market-Perform | Bernstein Research |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.